← Leaderboards
Yi-Chieh Nancy Du
Weill Medical Coll Of Cornell Univ
$3,693,887
Attributed
$3,906,517
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $406.6K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,906,517 · 3
By mechanism
R01$3,481,257 · 2
R21$425,260 · 1
Top collaborators
- Xuejun Jiang2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Andrew Griswold$193,070
- Bo Liu$12,386,108
- Tanya Schild$133,584
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellInsightIn VitroOverexpressionTumorMolecularMouse ModelXenograft ProcedureNeoplasm MetastasisGenesIslet Cell TumorIn VivoMediatingMalignant NeoplasmsCellsReportingSignal TransductionTumor Cell LineGenetically Engineered MouseMutantPublishingDisseminated Malignant NeoplasmMigrationComplex
Grant awards (11)
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis$387,731
R01 · FY2025 · CA · contact PI
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis$368,346
R01 · FY2024 · CA · contact PI
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis$379,977
R01 · FY2023 · CA · contact PI
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis$387,731
R01 · FY2022 · CA · contact PI
Beyond apoptosis, Bcl-xL in tumor metastasis$390,659
R01 · FY2021 · CA · contact PI
Beyond apoptosis, Bcl-xL in tumor metastasis$390,659
R01 · FY2020 · CA · contact PI
Beyond apoptosis, Bcl-xL in tumor metastasis$378,938
R01 · FY2019 · CA · contact PI
Beyond apoptosis, Bcl-xL in tumor metastasis$390,659
R01 · FY2018 · CA · contact PI
Beyond apoptosis, Bcl-xL in tumor metastasis$406,557
R01 · FY2017 · CA · contact PI
Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis$182,799
R21 · FY2014 · CA · contact PI
Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis$242,461
R21 · FY2013 · CA · contact PI